SEC Filing Details
Document Details
Form
Filing Date
Mar 1, 2023
Document Date
Dec 9, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.